[ad_1]
Unknown disease found in American vaccine tester
The Johnson & Johnson vaccine was going through the third phase of trials, in which 60,000 volunteers were planned.
American company Johnson and Johnson has suspended doses of its COVID-19 vaccine to trial participants due to an unknown illness in a volunteer. The corresponding statement was published on Monday, October 12, on the company’s website.
“We have temporarily suspended further distribution of vaccine doses for coronavirus-induced COVID-19 disease in all of our trials, including the third phase, due to unexplained illness in one trial participant,” the press release said.
The patient’s condition is currently being studied. Additional information about your health will be published after collecting all the necessary information.
By the end of September Johnson and Johnson began the third phase of clinical trials of its vaccine. The study involves 60,000 volunteers in eight countries on three continents. The company hoped that if the vaccine had proven its efficacy and safety, the first batches would be available for certification in early 2021.
It was previously reported that the Office of the President is considering three options to obtain a coronavirus vaccine, among which there is no possibility of deliveries from Russia.
News of Correspondent.net on Telegram. Subscribe to our channel https://t.me/korrespondentnet
